SCHEMBL10690916

SCHEMBL10690916

CC1NC(=O)NN=C1c1ccc(-n2ccnc2)nc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE3B Q13370 10/20 0.46
▸ PDE3A Q14432 10/20 0.46
▸ PDE4A P27815 3/20 0.46
▸ PDE4B Q07343 3/20 0.46
▸ PDE4C Q08493 3/20 0.46
▸ PDE4D Q08499 3/20 0.46
▸ PDE2A O00408 1/20 0.42
▸ FBP1 P09467 1/20 0.37
▸ GPR119 Q8TDV5 1/20 0.37
▸ CYP1A2 P05177 5/20 0.37
▸ CYP3A4 P08684 5/20 0.37
▸ CYP2D6 P10635 5/20 0.37
▸ CYP2C19 P33261 5/20 0.37
▸ CYP2C9 P11712 3/20 0.37
▸ TSHR P16473 2/20 0.37
▸ MAPK1 P28482 2/20 0.37
▸ LMNA P02545 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ GAA P10253 1/20 0.36
▸ PIM1 P11309 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10469492 0.81 PDE3B (0.71) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL10554320 0.76 PDE3B (0.46) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL10470250 0.73 CYP1A2 (0.40) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL10468163 0.72 PDE3A (0.70) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL10468427 0.71 PDE3B (0.69) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL10551860 0.71 PDE3B (0.46) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL10469541 0.69 PDE3B (0.52) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL10550384 0.69 PDE3B (0.46) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL10684945 0.69 PDE3B (0.44) PDE3BPDE3APDE4APDE4BPDE4C
SCHEMBL10887841 0.69 PDE3B (0.47) PDE3BPDE3APDE4APDE4BPDE4C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0255704-A2 Pyridazinone derivatives, process for their preparation and their use as medicines Roche Diagnostics GmbH (DE) 1988-02-10 — — EP disclosed
Send feedback